282 child-specific drugs are in the pipeline, group says

01/15/2012 | PharmaTimes (U.K.)

The biopharmaceutical industry has 282 drugs undergoing clinical development or FDA evaluation for conditions affecting the pediatric population, the Pharmaceutical Research and Manufacturers of America reported. The lineup includes therapeutic candidates for cancer, infectious diseases, genetic diseases and neurological illnesses. Researchers are also evaluating many existing drugs for use in children.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX